LB Pharmaceuticals Inc Common Stock
(LBRX - NASDAQ)
49,34 USD
📋 Profilo Aziendale

This biopharmaceutical firm is currently in the clinical development stage, concentrating on the creation of innovative treatments for neuropsychiatric disorders such as schizophrenia and bipolar depression.

|